ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Biomarkers for Signing Cancer Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-38B11183
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Biomarkers for Signing Cancer Market Research Report 2022
BUY CHAPTERS

Global Biomarkers for Signing Cancer Market Research Report 2025

Code: QYRE-Auto-38B11183
Report
March 2025
Pages:98
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Bristol Myers Squibb Company
Sysmex Corporation
Qiagen NV
Becton Dickinson and Company
Agilent Technologies
Abbott Laboratories
Hologic Inc
Quest Diagnostics
BioMérieux SA
Illumina Inc
Merck KGaA
Exact Sciences Corporation
F Hoffmann La Roche Ltd
Roche Diagnostics
Thermo Fisher Scientific Inc
Bio-Rad Laboratories Inc

Biomarkers for Signing Cancer Market Size

The global market for Biomarkers for Signing Cancer was valued at US$ 20440 million in the year 2024 and is projected to reach a revised size of US$ 47830 million by 2031, growing at a CAGR of 13.1% during the forecast period.

Biomarkers for Signing Cancer Market

Biomarkers for Signing Cancer Market

North American market for Biomarkers for Signing Cancer is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Biomarkers for Signing Cancer is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Biomarkers for Signing Cancer in Diagnostics is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Biomarkers for Signing Cancer include Bristol-Myers Squibb Company, Sysmex Corporation, QIAGEN, Becton, Dickinson and Company, Agilent Technologies, Abbott Laboratories, Hologic, Quest Diagnostics, Biomérieux SA, Illumina, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Biomarkers for Signing Cancer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biomarkers for Signing Cancer.
The Biomarkers for Signing Cancer market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Biomarkers for Signing Cancer market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biomarkers for Signing Cancer companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Biomarkers for Signing Cancer Market Report

Report Metric Details
Report Name Biomarkers for Signing Cancer Market
Accounted market size in year US$ 20440 million
Forecasted market size in 2031 US$ 47830 million
CAGR 13.1%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Genetic Biomarkers
  • Protein Biomarkers
  • Glyco-biomarkers
Segment by Application
  • Diagnostics
  • Drug Discovery and Development
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Bristol-Myers Squibb Company, Sysmex Corporation, QIAGEN, Becton, Dickinson and Company, Agilent Technologies, Abbott Laboratories, Hologic, Quest Diagnostics, Biomérieux SA, Illumina, Merck KGaA, Exact Sciences Corporation, F.Hoffmann-La Roche Ltd, Roche Diagnostics, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Biomarkers for Signing Cancer company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Biomarkers for Signing Cancer Market growing?

Ans: The Biomarkers for Signing Cancer Market witnessing a CAGR of 13.1% during the forecast period 2025-2031.

What is the Biomarkers for Signing Cancer Market size in 2031?

Ans: The Biomarkers for Signing Cancer Market size in 2031 will be US$ 47830 million.

Who are the main players in the Biomarkers for Signing Cancer Market report?

Ans: The main players in the Biomarkers for Signing Cancer Market are Bristol-Myers Squibb Company, Sysmex Corporation, QIAGEN, Becton, Dickinson and Company, Agilent Technologies, Abbott Laboratories, Hologic, Quest Diagnostics, Biomérieux SA, Illumina, Merck KGaA, Exact Sciences Corporation, F.Hoffmann-La Roche Ltd, Roche Diagnostics, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc

What are the Application segmentation covered in the Biomarkers for Signing Cancer Market report?

Ans: The Applications covered in the Biomarkers for Signing Cancer Market report are Diagnostics, Drug Discovery and Development, Others

What are the Type segmentation covered in the Biomarkers for Signing Cancer Market report?

Ans: The Types covered in the Biomarkers for Signing Cancer Market report are Genetic Biomarkers, Protein Biomarkers, Glyco-biomarkers

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biomarkers for Signing Cancer Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Genetic Biomarkers
1.2.3 Protein Biomarkers
1.2.4 Glyco-biomarkers
1.3 Market by Application
1.3.1 Global Biomarkers for Signing Cancer Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Diagnostics
1.3.3 Drug Discovery and Development
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biomarkers for Signing Cancer Market Perspective (2020-2031)
2.2 Global Biomarkers for Signing Cancer Growth Trends by Region
2.2.1 Global Biomarkers for Signing Cancer Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Biomarkers for Signing Cancer Historic Market Size by Region (2020-2025)
2.2.3 Biomarkers for Signing Cancer Forecasted Market Size by Region (2026-2031)
2.3 Biomarkers for Signing Cancer Market Dynamics
2.3.1 Biomarkers for Signing Cancer Industry Trends
2.3.2 Biomarkers for Signing Cancer Market Drivers
2.3.3 Biomarkers for Signing Cancer Market Challenges
2.3.4 Biomarkers for Signing Cancer Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biomarkers for Signing Cancer Players by Revenue
3.1.1 Global Top Biomarkers for Signing Cancer Players by Revenue (2020-2025)
3.1.2 Global Biomarkers for Signing Cancer Revenue Market Share by Players (2020-2025)
3.2 Global Biomarkers for Signing Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Biomarkers for Signing Cancer Revenue
3.4 Global Biomarkers for Signing Cancer Market Concentration Ratio
3.4.1 Global Biomarkers for Signing Cancer Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biomarkers for Signing Cancer Revenue in 2024
3.5 Global Key Players of Biomarkers for Signing Cancer Head office and Area Served
3.6 Global Key Players of Biomarkers for Signing Cancer, Product and Application
3.7 Global Key Players of Biomarkers for Signing Cancer, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Biomarkers for Signing Cancer Breakdown Data by Type
4.1 Global Biomarkers for Signing Cancer Historic Market Size by Type (2020-2025)
4.2 Global Biomarkers for Signing Cancer Forecasted Market Size by Type (2026-2031)
5 Biomarkers for Signing Cancer Breakdown Data by Application
5.1 Global Biomarkers for Signing Cancer Historic Market Size by Application (2020-2025)
5.2 Global Biomarkers for Signing Cancer Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Biomarkers for Signing Cancer Market Size (2020-2031)
6.2 North America Biomarkers for Signing Cancer Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Biomarkers for Signing Cancer Market Size by Country (2020-2025)
6.4 North America Biomarkers for Signing Cancer Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biomarkers for Signing Cancer Market Size (2020-2031)
7.2 Europe Biomarkers for Signing Cancer Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Biomarkers for Signing Cancer Market Size by Country (2020-2025)
7.4 Europe Biomarkers for Signing Cancer Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biomarkers for Signing Cancer Market Size (2020-2031)
8.2 Asia-Pacific Biomarkers for Signing Cancer Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Biomarkers for Signing Cancer Market Size by Region (2020-2025)
8.4 Asia-Pacific Biomarkers for Signing Cancer Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biomarkers for Signing Cancer Market Size (2020-2031)
9.2 Latin America Biomarkers for Signing Cancer Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Biomarkers for Signing Cancer Market Size by Country (2020-2025)
9.4 Latin America Biomarkers for Signing Cancer Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biomarkers for Signing Cancer Market Size (2020-2031)
10.2 Middle East & Africa Biomarkers for Signing Cancer Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Biomarkers for Signing Cancer Market Size by Country (2020-2025)
10.4 Middle East & Africa Biomarkers for Signing Cancer Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bristol-Myers Squibb Company
11.1.1 Bristol-Myers Squibb Company Company Details
11.1.2 Bristol-Myers Squibb Company Business Overview
11.1.3 Bristol-Myers Squibb Company Biomarkers for Signing Cancer Introduction
11.1.4 Bristol-Myers Squibb Company Revenue in Biomarkers for Signing Cancer Business (2020-2025)
11.1.5 Bristol-Myers Squibb Company Recent Development
11.2 Sysmex Corporation
11.2.1 Sysmex Corporation Company Details
11.2.2 Sysmex Corporation Business Overview
11.2.3 Sysmex Corporation Biomarkers for Signing Cancer Introduction
11.2.4 Sysmex Corporation Revenue in Biomarkers for Signing Cancer Business (2020-2025)
11.2.5 Sysmex Corporation Recent Development
11.3 QIAGEN
11.3.1 QIAGEN Company Details
11.3.2 QIAGEN Business Overview
11.3.3 QIAGEN Biomarkers for Signing Cancer Introduction
11.3.4 QIAGEN Revenue in Biomarkers for Signing Cancer Business (2020-2025)
11.3.5 QIAGEN Recent Development
11.4 Becton, Dickinson and Company
11.4.1 Becton, Dickinson and Company Company Details
11.4.2 Becton, Dickinson and Company Business Overview
11.4.3 Becton, Dickinson and Company Biomarkers for Signing Cancer Introduction
11.4.4 Becton, Dickinson and Company Revenue in Biomarkers for Signing Cancer Business (2020-2025)
11.4.5 Becton, Dickinson and Company Recent Development
11.5 Agilent Technologies
11.5.1 Agilent Technologies Company Details
11.5.2 Agilent Technologies Business Overview
11.5.3 Agilent Technologies Biomarkers for Signing Cancer Introduction
11.5.4 Agilent Technologies Revenue in Biomarkers for Signing Cancer Business (2020-2025)
11.5.5 Agilent Technologies Recent Development
11.6 Abbott Laboratories
11.6.1 Abbott Laboratories Company Details
11.6.2 Abbott Laboratories Business Overview
11.6.3 Abbott Laboratories Biomarkers for Signing Cancer Introduction
11.6.4 Abbott Laboratories Revenue in Biomarkers for Signing Cancer Business (2020-2025)
11.6.5 Abbott Laboratories Recent Development
11.7 Hologic
11.7.1 Hologic Company Details
11.7.2 Hologic Business Overview
11.7.3 Hologic Biomarkers for Signing Cancer Introduction
11.7.4 Hologic Revenue in Biomarkers for Signing Cancer Business (2020-2025)
11.7.5 Hologic Recent Development
11.8 Quest Diagnostics
11.8.1 Quest Diagnostics Company Details
11.8.2 Quest Diagnostics Business Overview
11.8.3 Quest Diagnostics Biomarkers for Signing Cancer Introduction
11.8.4 Quest Diagnostics Revenue in Biomarkers for Signing Cancer Business (2020-2025)
11.8.5 Quest Diagnostics Recent Development
11.9 Biomérieux SA
11.9.1 Biomérieux SA Company Details
11.9.2 Biomérieux SA Business Overview
11.9.3 Biomérieux SA Biomarkers for Signing Cancer Introduction
11.9.4 Biomérieux SA Revenue in Biomarkers for Signing Cancer Business (2020-2025)
11.9.5 Biomérieux SA Recent Development
11.10 Illumina
11.10.1 Illumina Company Details
11.10.2 Illumina Business Overview
11.10.3 Illumina Biomarkers for Signing Cancer Introduction
11.10.4 Illumina Revenue in Biomarkers for Signing Cancer Business (2020-2025)
11.10.5 Illumina Recent Development
11.11 Merck KGaA
11.11.1 Merck KGaA Company Details
11.11.2 Merck KGaA Business Overview
11.11.3 Merck KGaA Biomarkers for Signing Cancer Introduction
11.11.4 Merck KGaA Revenue in Biomarkers for Signing Cancer Business (2020-2025)
11.11.5 Merck KGaA Recent Development
11.12 Exact Sciences Corporation
11.12.1 Exact Sciences Corporation Company Details
11.12.2 Exact Sciences Corporation Business Overview
11.12.3 Exact Sciences Corporation Biomarkers for Signing Cancer Introduction
11.12.4 Exact Sciences Corporation Revenue in Biomarkers for Signing Cancer Business (2020-2025)
11.12.5 Exact Sciences Corporation Recent Development
11.13 F.Hoffmann-La Roche Ltd
11.13.1 F.Hoffmann-La Roche Ltd Company Details
11.13.2 F.Hoffmann-La Roche Ltd Business Overview
11.13.3 F.Hoffmann-La Roche Ltd Biomarkers for Signing Cancer Introduction
11.13.4 F.Hoffmann-La Roche Ltd Revenue in Biomarkers for Signing Cancer Business (2020-2025)
11.13.5 F.Hoffmann-La Roche Ltd Recent Development
11.14 Roche Diagnostics
11.14.1 Roche Diagnostics Company Details
11.14.2 Roche Diagnostics Business Overview
11.14.3 Roche Diagnostics Biomarkers for Signing Cancer Introduction
11.14.4 Roche Diagnostics Revenue in Biomarkers for Signing Cancer Business (2020-2025)
11.14.5 Roche Diagnostics Recent Development
11.15 Thermo Fisher Scientific, Inc.
11.15.1 Thermo Fisher Scientific, Inc. Company Details
11.15.2 Thermo Fisher Scientific, Inc. Business Overview
11.15.3 Thermo Fisher Scientific, Inc. Biomarkers for Signing Cancer Introduction
11.15.4 Thermo Fisher Scientific, Inc. Revenue in Biomarkers for Signing Cancer Business (2020-2025)
11.15.5 Thermo Fisher Scientific, Inc. Recent Development
11.16 Bio-Rad Laboratories, Inc
11.16.1 Bio-Rad Laboratories, Inc Company Details
11.16.2 Bio-Rad Laboratories, Inc Business Overview
11.16.3 Bio-Rad Laboratories, Inc Biomarkers for Signing Cancer Introduction
11.16.4 Bio-Rad Laboratories, Inc Revenue in Biomarkers for Signing Cancer Business (2020-2025)
11.16.5 Bio-Rad Laboratories, Inc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Bristol Myers Squibb Company
Sysmex Corporation
Qiagen NV
Becton Dickinson and Company
Agilent Technologies
Abbott Laboratories
Hologic Inc
Quest Diagnostics
BioMérieux SA
Illumina Inc
Merck KGaA
Exact Sciences Corporation
F Hoffmann La Roche Ltd
Roche Diagnostics
Thermo Fisher Scientific Inc
Bio-Rad Laboratories Inc
List of Tables
 Table 1. Global Biomarkers for Signing Cancer Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Genetic Biomarkers
 Table 3. Key Players of Protein Biomarkers
 Table 4. Key Players of Glyco-biomarkers
 Table 5. Global Biomarkers for Signing Cancer Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Biomarkers for Signing Cancer Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Biomarkers for Signing Cancer Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Biomarkers for Signing Cancer Market Share by Region (2020-2025)
 Table 9. Global Biomarkers for Signing Cancer Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Biomarkers for Signing Cancer Market Share by Region (2026-2031)
 Table 11. Biomarkers for Signing Cancer Market Trends
 Table 12. Biomarkers for Signing Cancer Market Drivers
 Table 13. Biomarkers for Signing Cancer Market Challenges
 Table 14. Biomarkers for Signing Cancer Market Restraints
 Table 15. Global Biomarkers for Signing Cancer Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Biomarkers for Signing Cancer Market Share by Players (2020-2025)
 Table 17. Global Top Biomarkers for Signing Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biomarkers for Signing Cancer as of 2024)
 Table 18. Ranking of Global Top Biomarkers for Signing Cancer Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Biomarkers for Signing Cancer Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Biomarkers for Signing Cancer, Headquarters and Area Served
 Table 21. Global Key Players of Biomarkers for Signing Cancer, Product and Application
 Table 22. Global Key Players of Biomarkers for Signing Cancer, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Biomarkers for Signing Cancer Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Biomarkers for Signing Cancer Revenue Market Share by Type (2020-2025)
 Table 26. Global Biomarkers for Signing Cancer Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Biomarkers for Signing Cancer Revenue Market Share by Type (2026-2031)
 Table 28. Global Biomarkers for Signing Cancer Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Biomarkers for Signing Cancer Revenue Market Share by Application (2020-2025)
 Table 30. Global Biomarkers for Signing Cancer Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Biomarkers for Signing Cancer Revenue Market Share by Application (2026-2031)
 Table 32. North America Biomarkers for Signing Cancer Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Biomarkers for Signing Cancer Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Biomarkers for Signing Cancer Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Biomarkers for Signing Cancer Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Biomarkers for Signing Cancer Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Biomarkers for Signing Cancer Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Biomarkers for Signing Cancer Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Biomarkers for Signing Cancer Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Biomarkers for Signing Cancer Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Biomarkers for Signing Cancer Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Biomarkers for Signing Cancer Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Biomarkers for Signing Cancer Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Biomarkers for Signing Cancer Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Biomarkers for Signing Cancer Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Biomarkers for Signing Cancer Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Bristol-Myers Squibb Company Company Details
 Table 48. Bristol-Myers Squibb Company Business Overview
 Table 49. Bristol-Myers Squibb Company Biomarkers for Signing Cancer Product
 Table 50. Bristol-Myers Squibb Company Revenue in Biomarkers for Signing Cancer Business (2020-2025) & (US$ Million)
 Table 51. Bristol-Myers Squibb Company Recent Development
 Table 52. Sysmex Corporation Company Details
 Table 53. Sysmex Corporation Business Overview
 Table 54. Sysmex Corporation Biomarkers for Signing Cancer Product
 Table 55. Sysmex Corporation Revenue in Biomarkers for Signing Cancer Business (2020-2025) & (US$ Million)
 Table 56. Sysmex Corporation Recent Development
 Table 57. QIAGEN Company Details
 Table 58. QIAGEN Business Overview
 Table 59. QIAGEN Biomarkers for Signing Cancer Product
 Table 60. QIAGEN Revenue in Biomarkers for Signing Cancer Business (2020-2025) & (US$ Million)
 Table 61. QIAGEN Recent Development
 Table 62. Becton, Dickinson and Company Company Details
 Table 63. Becton, Dickinson and Company Business Overview
 Table 64. Becton, Dickinson and Company Biomarkers for Signing Cancer Product
 Table 65. Becton, Dickinson and Company Revenue in Biomarkers for Signing Cancer Business (2020-2025) & (US$ Million)
 Table 66. Becton, Dickinson and Company Recent Development
 Table 67. Agilent Technologies Company Details
 Table 68. Agilent Technologies Business Overview
 Table 69. Agilent Technologies Biomarkers for Signing Cancer Product
 Table 70. Agilent Technologies Revenue in Biomarkers for Signing Cancer Business (2020-2025) & (US$ Million)
 Table 71. Agilent Technologies Recent Development
 Table 72. Abbott Laboratories Company Details
 Table 73. Abbott Laboratories Business Overview
 Table 74. Abbott Laboratories Biomarkers for Signing Cancer Product
 Table 75. Abbott Laboratories Revenue in Biomarkers for Signing Cancer Business (2020-2025) & (US$ Million)
 Table 76. Abbott Laboratories Recent Development
 Table 77. Hologic Company Details
 Table 78. Hologic Business Overview
 Table 79. Hologic Biomarkers for Signing Cancer Product
 Table 80. Hologic Revenue in Biomarkers for Signing Cancer Business (2020-2025) & (US$ Million)
 Table 81. Hologic Recent Development
 Table 82. Quest Diagnostics Company Details
 Table 83. Quest Diagnostics Business Overview
 Table 84. Quest Diagnostics Biomarkers for Signing Cancer Product
 Table 85. Quest Diagnostics Revenue in Biomarkers for Signing Cancer Business (2020-2025) & (US$ Million)
 Table 86. Quest Diagnostics Recent Development
 Table 87. Biomérieux SA Company Details
 Table 88. Biomérieux SA Business Overview
 Table 89. Biomérieux SA Biomarkers for Signing Cancer Product
 Table 90. Biomérieux SA Revenue in Biomarkers for Signing Cancer Business (2020-2025) & (US$ Million)
 Table 91. Biomérieux SA Recent Development
 Table 92. Illumina Company Details
 Table 93. Illumina Business Overview
 Table 94. Illumina Biomarkers for Signing Cancer Product
 Table 95. Illumina Revenue in Biomarkers for Signing Cancer Business (2020-2025) & (US$ Million)
 Table 96. Illumina Recent Development
 Table 97. Merck KGaA Company Details
 Table 98. Merck KGaA Business Overview
 Table 99. Merck KGaA Biomarkers for Signing Cancer Product
 Table 100. Merck KGaA Revenue in Biomarkers for Signing Cancer Business (2020-2025) & (US$ Million)
 Table 101. Merck KGaA Recent Development
 Table 102. Exact Sciences Corporation Company Details
 Table 103. Exact Sciences Corporation Business Overview
 Table 104. Exact Sciences Corporation Biomarkers for Signing Cancer Product
 Table 105. Exact Sciences Corporation Revenue in Biomarkers for Signing Cancer Business (2020-2025) & (US$ Million)
 Table 106. Exact Sciences Corporation Recent Development
 Table 107. F.Hoffmann-La Roche Ltd Company Details
 Table 108. F.Hoffmann-La Roche Ltd Business Overview
 Table 109. F.Hoffmann-La Roche Ltd Biomarkers for Signing Cancer Product
 Table 110. F.Hoffmann-La Roche Ltd Revenue in Biomarkers for Signing Cancer Business (2020-2025) & (US$ Million)
 Table 111. F.Hoffmann-La Roche Ltd Recent Development
 Table 112. Roche Diagnostics Company Details
 Table 113. Roche Diagnostics Business Overview
 Table 114. Roche Diagnostics Biomarkers for Signing Cancer Product
 Table 115. Roche Diagnostics Revenue in Biomarkers for Signing Cancer Business (2020-2025) & (US$ Million)
 Table 116. Roche Diagnostics Recent Development
 Table 117. Thermo Fisher Scientific, Inc. Company Details
 Table 118. Thermo Fisher Scientific, Inc. Business Overview
 Table 119. Thermo Fisher Scientific, Inc. Biomarkers for Signing Cancer Product
 Table 120. Thermo Fisher Scientific, Inc. Revenue in Biomarkers for Signing Cancer Business (2020-2025) & (US$ Million)
 Table 121. Thermo Fisher Scientific, Inc. Recent Development
 Table 122. Bio-Rad Laboratories, Inc Company Details
 Table 123. Bio-Rad Laboratories, Inc Business Overview
 Table 124. Bio-Rad Laboratories, Inc Biomarkers for Signing Cancer Product
 Table 125. Bio-Rad Laboratories, Inc Revenue in Biomarkers for Signing Cancer Business (2020-2025) & (US$ Million)
 Table 126. Bio-Rad Laboratories, Inc Recent Development
 Table 127. Research Programs/Design for This Report
 Table 128. Key Data Information from Secondary Sources
 Table 129. Key Data Information from Primary Sources
 Table 130. Authors List of This Report


List of Figures
 Figure 1. Biomarkers for Signing Cancer Picture
 Figure 2. Global Biomarkers for Signing Cancer Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Biomarkers for Signing Cancer Market Share by Type: 2024 VS 2031
 Figure 4. Genetic Biomarkers Features
 Figure 5. Protein Biomarkers Features
 Figure 6. Glyco-biomarkers Features
 Figure 7. Global Biomarkers for Signing Cancer Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Biomarkers for Signing Cancer Market Share by Application: 2024 VS 2031
 Figure 9. Diagnostics Case Studies
 Figure 10. Drug Discovery and Development Case Studies
 Figure 11. Others Case Studies
 Figure 12. Biomarkers for Signing Cancer Report Years Considered
 Figure 13. Global Biomarkers for Signing Cancer Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Biomarkers for Signing Cancer Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Biomarkers for Signing Cancer Market Share by Region: 2024 VS 2031
 Figure 16. Global Biomarkers for Signing Cancer Market Share by Players in 2024
 Figure 17. Global Top Biomarkers for Signing Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biomarkers for Signing Cancer as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by Biomarkers for Signing Cancer Revenue in 2024
 Figure 19. North America Biomarkers for Signing Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Biomarkers for Signing Cancer Market Share by Country (2020-2031)
 Figure 21. United States Biomarkers for Signing Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Biomarkers for Signing Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Biomarkers for Signing Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Biomarkers for Signing Cancer Market Share by Country (2020-2031)
 Figure 25. Germany Biomarkers for Signing Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Biomarkers for Signing Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Biomarkers for Signing Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Biomarkers for Signing Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Biomarkers for Signing Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Biomarkers for Signing Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Biomarkers for Signing Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Biomarkers for Signing Cancer Market Share by Region (2020-2031)
 Figure 33. China Biomarkers for Signing Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Biomarkers for Signing Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Biomarkers for Signing Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Biomarkers for Signing Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Biomarkers for Signing Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Biomarkers for Signing Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Biomarkers for Signing Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Biomarkers for Signing Cancer Market Share by Country (2020-2031)
 Figure 41. Mexico Biomarkers for Signing Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Biomarkers for Signing Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Biomarkers for Signing Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Biomarkers for Signing Cancer Market Share by Country (2020-2031)
 Figure 45. Turkey Biomarkers for Signing Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Biomarkers for Signing Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Biomarkers for Signing Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Bristol-Myers Squibb Company Revenue Growth Rate in Biomarkers for Signing Cancer Business (2020-2025)
 Figure 49. Sysmex Corporation Revenue Growth Rate in Biomarkers for Signing Cancer Business (2020-2025)
 Figure 50. QIAGEN Revenue Growth Rate in Biomarkers for Signing Cancer Business (2020-2025)
 Figure 51. Becton, Dickinson and Company Revenue Growth Rate in Biomarkers for Signing Cancer Business (2020-2025)
 Figure 52. Agilent Technologies Revenue Growth Rate in Biomarkers for Signing Cancer Business (2020-2025)
 Figure 53. Abbott Laboratories Revenue Growth Rate in Biomarkers for Signing Cancer Business (2020-2025)
 Figure 54. Hologic Revenue Growth Rate in Biomarkers for Signing Cancer Business (2020-2025)
 Figure 55. Quest Diagnostics Revenue Growth Rate in Biomarkers for Signing Cancer Business (2020-2025)
 Figure 56. Biomérieux SA Revenue Growth Rate in Biomarkers for Signing Cancer Business (2020-2025)
 Figure 57. Illumina Revenue Growth Rate in Biomarkers for Signing Cancer Business (2020-2025)
 Figure 58. Merck KGaA Revenue Growth Rate in Biomarkers for Signing Cancer Business (2020-2025)
 Figure 59. Exact Sciences Corporation Revenue Growth Rate in Biomarkers for Signing Cancer Business (2020-2025)
 Figure 60. F.Hoffmann-La Roche Ltd Revenue Growth Rate in Biomarkers for Signing Cancer Business (2020-2025)
 Figure 61. Roche Diagnostics Revenue Growth Rate in Biomarkers for Signing Cancer Business (2020-2025)
 Figure 62. Thermo Fisher Scientific, Inc. Revenue Growth Rate in Biomarkers for Signing Cancer Business (2020-2025)
 Figure 63. Bio-Rad Laboratories, Inc Revenue Growth Rate in Biomarkers for Signing Cancer Business (2020-2025)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

Global Imaging Biomarker Market Research Report 2025
Global Tumor Biomarker Test Market Research Report 2024
Global Genomic Biomarkers Market Research Report 2024
Stroke Testing Biomarkers Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Renal Biomarker Market Research Report 2025
Next Generation Cancer Diagnostics Market
Global Tumor Markers Immunoassay Market Research Report 2024
Global Tumor Marker Detection Products Market Insights Forecast to 2030
Global Tumor Markers Detection Kit Market Research Report 2025
Global Antibodies and Antigens to Cardiovascular Biomarkers Market Research Report 2025
Global Rapid Tumor Marker Tests Market Research Report 2025
Global Tumor Marker Testing Market Research Report 2024
Global Rare Biomarkers Market Research Report 2024
Global Alzheimer s Disease Biomarker Market Research Report 2024
Global Acute Myeloid Leukemia AML Biomarker Testing Market Research Report 2025
Lung Cancer Liquid Biops Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Tumor Marker Test Kit Market Research Report 2025
Global Circulating Biomarker for Liquid Biopsy Market Research Report 2024
Global Predisposition Biomarkers Market Research Report 2024
Global Biomarker POCT Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions